News Archives - SOHO Insider

Skip to content

What are the DREAMM-7 and DREAMM-8 trials?
Selina Luger, MD, weighs the promise and challenges of modern ALL care
Register for SOHO Breakthroughs in Blood Cancers
Save the date: SOHO 2027 scheduled for August 25–28
FDA approves 1st new treatment for essential thrombocythemia in nearly three decades

Insider Reader Survey

Join SOHO

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

FDA approves 1st new treatment for essential thrombocythemia in nearly three decades

by SOHO Insider Editors
September 24, 2026
0 Comments

Acute Lymphoblastic Leukemia News SOHO 2026 Meetings / Conferences News

Dose-dense mini-CVD plus inotuzumab ozogamicin, blinatumomab demonstrates deep, durable responses in relapsed or refractory B-ALL

by Patrick Daly
September 23, 2026
0 Comments

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda

Myeloproliferative Neoplasms Primary Myelofibrosis News

FDA receives sNDA for selinexor, ruxolitinib in myelofibrosis

by SOHO Insider Editors
September 22, 2026
0 Comments

Myelodysplastic Syndromes News

LYT-200 receives FDA Fast Track Designation for relapsed or refractory high-risk MDS

by SOHO Insider Editors
September 22, 2026
0 Comments

News Society Updates

4th SOHO Israel Meeting registration open, meeting to be held November 19–20, 2026

by SOHO Insider Editors
September 22, 2026
0 Comments

Trending now News

Fibrotic low-risk MDS associated with elevated IL-1β and reduced IL-5

by Leah Sherwood
September 13, 2026
0 Comments

Soho Print News

SOHO Insider Daily, Newspaper Volume 4

by Leah Sherwood
September 12, 2026
0 Comments

Soho Print News

SOHO Insider Daily, Newspaper Volume 3

by Leah Sherwood
September 11, 2026
0 Comments

MDS News SOHO 2026 Meetings / Conferences News

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

by Leah Sherwood
September 10, 2026
0 Comments

SOHO 2026 News

Dr. Maddocks previews Friday MCL session at SOHO 2026

by Kami Maddocks, MD
September 10, 2026
0 Comments

1
2
3
...
34

Top Categories

Cellular Therapy

83

Leukemia

135

Lymphoma

143

Multiple Myeloma

122

Myelodysplastic Syndromes

51

Myeloproliferative Neoplasms

39

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

FDA approves 1st new treatment for essential thrombocythemia in nearly three decades

Dose-dense mini-CVD plus inotuzumab ozogamicin, blinatumomab demonstrates deep, durable responses in relapsed or refractory B-ALL

FDA receives sNDA for selinexor, ruxolitinib in myelofibrosis

LYT-200 receives FDA Fast Track Designation for relapsed or refractory high-risk MDS

4th SOHO Israel Meeting registration open, meeting to be held November 19–20, 2026

SOHO Insider Daily, Newspaper Volume 4

SOHO Insider Daily, Newspaper Volume 3

SOHO 2026 Friday plenary features NIH scientist and aplastic anemia expert Dr. Neal S. Young

Dr. Maddocks previews Friday MCL session at SOHO 2026

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

What are the DREAMM-7 and DREAMM-8 trials?

Selina Luger, MD, weighs the promise and challenges of modern ALL care

Register for SOHO Breakthroughs in Blood Cancers

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms